The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a sole-source contract for preventative maintenance services for three Sepax Pro Cell Processing Systems used in cell therapy manufacturing and research. The contract will be awarded to Global Life Sciences Solutions USA LLC, the only vendor authorized to perform these services due to the proprietary nature of the equipment and the requirement for compliance with FDA regulations regarding critical equipment maintenance. The period of performance for this contract is set from January 27, 2025, to January 26, 2026, with interested parties encouraged to submit capability statements by December 28, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.